Evaluation of the pharmacodynamic activity of insulin from bilosomal formulation

Current Drug Delivery

Volumn 6, Issue 4, 2009, Pages 415-418

  Ayogu, I J ^a   Ogbonna, O ^b   Ayolugbe, C I ^a   Attama, A A ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Bilosome; Bioavailability; Blood glucose reduction; Drug delivery system; Formulation; Insulin

Indexed keywords

BILE SALT; BILOSOME I; BILOSOME II; CHOLESTEROL; DEOXYCHOLATE SODIUM; GLUCOSE; INSULIN; PALMITIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SOYBEAN; STREPTOZOCIN DIABETES;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DEOXYCHOLIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOSOMES; MALE; PALMITIC ACID; RATS; RATS, WISTAR; SOYBEANS; STREPTOZOCIN;

EID: 68949085151     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109789000573     Document Type: Article

References (28)

1. Nakamura, K.; Murray, R. J.; Joseph, J. I.; Peppas, N.A.; Morishita, M.; Lowman, A.M. Oral insulin delivery using P(MAA-g-EG) hydrogels: Effects of network morphology on insulin delivery characteristics. J. Control. Release, 2004, 95, 589-599.
2. Sajeesh, S.; Sharma, C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm., 2006, 325, 147-154. (Pubitemid 44573692)
3. Jain, D.; Panda, A.K.; Majumdar, D.K. Eudragit S100 entraped insulin microspheres for oral delivery. AAPS Pharmscitech., 2005, 1-27.
4. Gwinup, G.; Elias, A.N.; Vaziri, N.D. A case for oral insulin therapy in the prevention of diabetic micro and macro angioparthy. Int. J. Artif. Organ, 1990. 13, 393-395.
5. Morishita, M.; Goto, T.; Nakamura, K.; Lowman, A.M.; Takayama, K.; Peppas, N.A. Oral insulin delivery system based on complexation polymer hydrogels:single and multiple administration studies in type 1 and type 2 diabetic rats. J. Control. Release, 2006, 110, 587-594.
6. Agarwal, V.; Khan, M.A. Current status of oral delivery of insulin. Pharm. Technol., 2001, 10, 76-90. (Pubitemid 33029319)
7. Gowthamarajan, K.; Kulkarni, G.T. Possibilities for achieving oral delivery of insulin - fact or fiction? Resonance, 2003, 8, 38-46.
8. Korytkowski, M. When oral agents fails: Practical barriers to starting insulin. Int. J. Obesity, 2002, 26 (Supl 3), S18-S24. (Pubitemid 35034478)
9. Lin, Y.H.; Mi, F.L.; Chen, C.T. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules, 2007, 8, 146-152. (Pubitemid 46140485)
10. Li, C.L.; Deng, Y.J. Oil based formulation for oral delivery of insulin. J. Pharm. Pharmacol., 2004, 56, 1101-1109.
11. Timmy, S.A; Victor, S.P; Sharma, C.P; Kumari, V..J. Betacyclodextrin complexed insulin loaded alginate microsphere-oral delivery system. Trends Biomater. Artif. Organs., 2002, 15, 48-53.
12. Qi, R.; Ping, Q.N. gastrointestinal absorption enhancement of insulin by administration of enteric microsphere and SNAC to rats. J. Microencapsul., 2004, 21, 37-45.
13. Zhang, N.; Ping, Q. Huang, G.; Xu, W.; Cheng, Y.; Han, X. Lectin modified solid lipid nanoparticles as carrier for oral administration of insulin. Int. J. Pharm., 2006, 327, 153-159. (Pubitemid 44667334)
14. Kipnes, M.; Still, J.G.; Dandona, P.; Tripathy, D. Control of postprandial plasma glucose an oral insulin product(HIM2) in patients withtype 2 diabetes. Diabetes Care, 2003, 26, 421-426. (Pubitemid 36929066)
15. Cho, Y.W; Flynn, M. Oral delivery of insulin. Lancet, 1989, ii, 1518-1519.
16. Sizer, P.J.H. Towards an oral influenza vaccine. Trends Biotechnol., 1997, 15, 282-285
17. Conacher, M.; Alexender, J.; Brewer, J.M. Oral immunization with peptide and protein antigens by formulation in lipid vesicles incorporating bile salt. Vaccine, 2001, 19, 2965-2974.
18. Aungst, B.J.; Saitah, H.; Burcham, D.L.; Huang, S.M.; Mousa, A.; Hussain, A. Enhancement of intestinal absorption of peptides and non peptides. J. Control. Release, 1996, 41, 19-31.
19. Kidron, M.; Bar-On, H.; E.M.; Ziv, E. The absorption of insulin from various regions of rat intestine. Life Sci., 1982, 31, 2837-2841. (Pubitemid 13212452)
20. Hirai, Y. T.; Mima, H. Mechanisms for enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm., 1981, 9, 173-184. (Pubitemid 11021848)
21. Aungst. B. J.; Rogers, N. J. Site dependence of absorptionpromoting action of laureth-9, sodium salicylate, sodium edentate and aprotinin on rectal, nasal and buccal insulin delivery. Pharm. Res., 1988, 5, 305-308.
22. Morishita, I.; Morishita, M.; Takayama, K.; Nagai, T. Hypoglycemic effect of novel oral microsphere of insulin with protease inhibitor in normal diabetic rat. Int. J. Pharm., 1992, 78, 9-16.
23. Silva-cunha, A.; Cheron, M.; Grossiord, J. L.; Puisieurx, F.; Seiller, M. w/o/w multiple emulsion of insulin containing a protease inhibitor and absorption enhancer: biological activity after oral administration to normal and diabetic rats. Int. J. Pharm., 1998, 169, 33-34.
24. Ziv, E. O.; Kidron, M. Absorption of protein in the intestinal wall: A quantitative model. Biochem. Pharmacol., 1987, 36, 1035-1039. (Pubitemid 17051093)
25. Bendayan, M.; Ziv, E.; Ben-Sasson, R.; Bar-On, H.; Kidron, M. Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia, 1990, 33, 197-204.
26. Zhou, X.H.; Po, A.L.W. Effect of cholic acid and absorption enhancer on the bioavailabilty of insulin from subcutaneous site. Int. J. Pharm., 1991, 69, 29-41.
27. Yahamoto, A.; Hayakawa, E.; Kato, Y.; Nishiura, A. A mechanistic study on enhancement ofrectal permeability of to insulin in albino rats. J. Pharmacol. Exp. Ther., 1992, 263, 25-31.
28. Li, Y.; Shao, Z.; Mitra, A.K. Dissociation of insulin oligomers by bile salt micelles and its effect on chymotrypsin mediated proteolytic degradation. Pharm. Res., 1992, 9, 864-1859